<- Go Home

Champions Oncology, Inc.

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Market Cap

$68.9M

Volume

14.1K

Cash and Equivalents

$4.4M

EBITDA

$402.0K

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$30.2M

Profit Margin

49.82%

52 Week High

$8.31

52 Week Low

$4.59

Dividend

N/A

Price / Book Value

17.71

Price / Earnings

-60.49

Price / Tangible Book Value

19.38

Enterprise Value

$76.1M

Enterprise Value / EBITDA

34.85

Operating Income

-$931.0K

Return on Equity

28.38%

Return on Assets

-1.82

Cash and Short Term Investments

$4.4M

Debt

$11.0M

Equity

$4.5M

Revenue

$60.7M

Unlevered FCF

-$5.5M

Sector

Life Sciences Tools and Services

Category

N/A

Company Stock Pitches